Sangamo Operating Cash Flow Per Share from 2010 to 2024
| SGMO Stock | USD 0.52 0.02 3.70% |
Operating Cash Flow Per Share | First Reported 2010-12-31 | Previous Quarter (1.29) | Current Value (1.22) | Quarterly Volatility 0.78851163 |
Check Sangamo Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sangamo main balance sheet or income statement drivers, such as Interest Expense of 11.4 M, Total Revenue of 185 M or Gross Profit of 161.7 M, as well as many exotic indicators such as Price To Sales Ratio of 0.51, Dividend Yield of 0.0 or PTB Ratio of 1.09. Sangamo financial statements analysis is a perfect complement when working with Sangamo Therapeutics Valuation or Volatility modules.
Sangamo | Operating Cash Flow Per Share |
Latest Sangamo Therapeutics' Operating Cash Flow Per Share Growth Pattern
Below is the plot of the Operating Cash Flow Per Share of Sangamo Therapeutics over the last few years. It is a measure of the cash generated from a company's normal business operations per share, indicating how much cash is generated from a company's business operations on a per-share basis. Sangamo Therapeutics' Operating Cash Flow Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sangamo Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Operating Cash Flow Per Share | 10 Years Trend |
|
Operating Cash Flow Per Share |
| Timeline |
Sangamo Operating Cash Flow Per Share Regression Statistics
| Arithmetic Mean | (0.53) | |
| Geometric Mean | 0.55 | |
| Coefficient Of Variation | (148.14) | |
| Mean Deviation | 0.61 | |
| Median | (0.48) | |
| Standard Deviation | 0.79 | |
| Sample Variance | 0.62 | |
| Range | 2.8769 | |
| R-Value | (0.37) | |
| Mean Square Error | 0.58 | |
| R-Squared | 0.14 | |
| Significance | 0.18 | |
| Slope | (0.06) | |
| Total Sum of Squares | 8.70 |
Sangamo Operating Cash Flow Per Share History
About Sangamo Therapeutics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Sangamo Therapeutics income statement, its balance sheet, and the statement of cash flows. Sangamo Therapeutics investors use historical funamental indicators, such as Sangamo Therapeutics's Operating Cash Flow Per Share, to determine how well the company is positioned to perform in the future. Although Sangamo Therapeutics investors may use each financial statement separately, they are all related. The changes in Sangamo Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Sangamo Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Sangamo Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Sangamo Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Operating Cash Flow Per Share | (1.29) | (1.22) |
Currently Active Assets on Macroaxis
When determining whether Sangamo Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sangamo Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sangamo Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sangamo Therapeutics Stock:Check out the analysis of Sangamo Therapeutics Correlation against competitors. To learn how to invest in Sangamo Stock, please use our How to Invest in Sangamo Therapeutics guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for Sangamo Stock analysis
When running Sangamo Therapeutics' price analysis, check to measure Sangamo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sangamo Therapeutics is operating at the current time. Most of Sangamo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Sangamo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sangamo Therapeutics' price. Additionally, you may evaluate how the addition of Sangamo Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
Is Sangamo Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sangamo Therapeutics. If investors know Sangamo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sangamo Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.48) | Revenue Per Share 1.01 | Quarterly Revenue Growth (0.93) | Return On Assets (0.18) | Return On Equity (1.36) |
The market value of Sangamo Therapeutics is measured differently than its book value, which is the value of Sangamo that is recorded on the company's balance sheet. Investors also form their own opinion of Sangamo Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Sangamo Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sangamo Therapeutics' market value can be influenced by many factors that don't directly affect Sangamo Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sangamo Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sangamo Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sangamo Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.